Frank DS - Search Results

1

Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) Copolymer.

Frank DS, Prasad P, Iuzzolino L, Schenck L. Frank DS, et al. Mol Pharm. 2022 Sep 5;19(9):3304-3313. doi: 10.1021/acs.molpharmaceut.2c00456. Epub 2022 Aug 19. Mol Pharm. 2022. PMID: 35985017

2

Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.

Frank DS, Matzger AJ. Frank DS, et al. Mol Pharm. 2018 Jul 2;15(7):2714-2720. doi: 10.1021/acs.molpharmaceut.8b00219. Epub 2018 Jun 20. Mol Pharm. 2018. PMID: 29924614 Free PMC article.

3

Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.

Frank DS, Matzger AJ. Frank DS, et al. Mol Pharm. 2019 Feb 4;16(2):682-688. doi: 10.1021/acs.molpharmaceut.8b00972. Epub 2019 Jan 15. Mol Pharm. 2019. PMID: 30645134 Free PMC article.

4

Inhibiting or Accelerating Crystallization of Pharmaceuticals by Manipulating Polymer Solubility.

Frank DS, Zhu Q, Matzger AJ. Frank DS, et al. Mol Pharm. 2019 Aug 5;16(8):3720-3725. doi: 10.1021/acs.molpharmaceut.9b00468. Epub 2019 Jul 8. Mol Pharm. 2019. PMID: 31268333

5

Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies.

Schenck L, Boyce C, Frank D, Koranne S, Ferguson HM, Strotman N. Schenck L, et al. Pharmaceutics. 2021 Jul 7;13(7):1034. doi: 10.3390/pharmaceutics13071034. Pharmaceutics. 2021. PMID: 34371726 Free PMC article.

6

Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of Posaconazole.

Frank D, Schenck L, Koynov A, Su Y, Li Y, Variankaval N. Frank D, et al. Pharmaceutics. 2021 Nov 26;13(12):2017. doi: 10.3390/pharmaceutics13122017. Pharmaceutics. 2021. PMID: 34959298 Free PMC article.

7

High Bulk-Density Amorphous Dispersions to Enable Direct Compression of Reduced Tablet Size Amorphous Dosage Units.

Frank DS, Nie H, Chandra A, Coelho A, Dalton C, Dvorak H, Elkhabaz A, Fahy M, Ormes J, Parker A, Punia A, Rowe J, Schenck L, Smith D, Strotman NA, Wang M, Wareham L. Frank DS, et al. J Pharm Sci. 2023 Aug;112(8):2037-2045. doi: 10.1016/j.xphs.2022.09.007. Epub 2022 Sep 14. J Pharm Sci. 2023. PMID: 36115592

8

Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder Properties.

Frank DS, Punia A, Fahy M, Dalton C, Rowe J, Schenck L. Frank DS, et al. Pharm Res. 2022 Dec;39(12):3197-3208. doi: 10.1007/s11095-022-03416-6. Epub 2022 Oct 21. Pharm Res. 2022. PMID: 36271203

9

Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions.

Kelsall KN, Foroughi LM, Frank DS, Schenck L, LaBuda A, Matzger AJ. Kelsall KN, et al. Among authors: frank ds. Mol Pharm. 2023 Mar 6;20(3):1779-1787. doi: 10.1021/acs.molpharmaceut.2c00970. Epub 2023 Jan 31. Mol Pharm. 2023. PMID: 36719910

10

Poly(vinylpyridine-co-vinylpyridine N-oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid Dispersions.

Liu YS, Della Rocca J, Schenck L, Koynov A, Sifri RJ, Winston MS, Frank DS. Liu YS, et al. Among authors: frank ds. Mol Pharm. 2024 Mar 4;21(3):1182-1191. doi: 10.1021/acs.molpharmaceut.3c00789. Epub 2024 Feb 7. Mol Pharm. 2024. PMID: 38323546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters